Thus, the PDGFRA signaling pathway is essential to promote KSHV-infected cell survival and proliferation allowing KSHV tumorigenesis to progress, further validating this oncogenic pathway as a therapeutic target for early stages of KS tumorigenesis (Fig 8). Here, PDGFRA is linked to Kaposi's sarcoma.